Unraveling the Complexities of Hypersensitivity Pneumonitis with Autoimmune Features: A Retrospective Analysis
Advances in Respiratory Medicine · 07.11.2025 · 93 (6) · 50
DOI: 10.3390/arm93060050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 07.11.2025. Verfasst von Joana Lourenço und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology Department, Unidade Local de Saúde de Matosinhos, 4464-513 Porto, Portugal. Hauptthemen laut MEDLINE: Alveolitis, Extrinsic Allergic, Pulmonary Fibrosis, Autoimmune Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Some hypersensitivity pneumonitis (HP) patients exhibit autoimmune features (HPAF). This study compared outcomes of HPAF and HP without autoimmune features, focusing on progressive pulmonary fibrosis (PPF) and response to immunosuppression.
Methods
A retrospective cohort study included HP patients from a single center. HPAF was defined as HP overlapping with autoimmune disease or presenting autoimmune markers/symptoms not fulfilling connective tissue disease criteria. A control HP group without autoimmune features was randomly selected. Demographics, autoimmune profiles, and outcomes over two years were analyzed.
Results
103 patients were included (52 HPAF; 51 HP). In HPAF, the most common autoimmune diseases were rheumatoid arthritis (9.6%), while 57.7% had isolated autoimmune serology. Groups showed no baseline differences in demographics, exposures, smoking, or lung function. Fibrotic disease on high-resolution CT at diagnosis was less frequent in HPAF (71.2% vs. 88.2%; p = 0.031). At two-year follow-up, survival, transplantation, and PPF prevalence were similar. HPAF patients received immunosuppression less often (69.2% vs. 86.3%; p = 0.038). Among patients under immunosuppression, PPF was significantly lower in HPAF group (8.6% vs. 29.5%; p = 0.021).
Conclusions
Within two years post-diagnosis, HPAF and HP had comparable overall outcomes. However, under immunosuppression, HPAF patients had significantly lower odds of developing PPF (adjusted OR 0.08; 95% CI 0.008–0.816; p = 0.033) compared to HP patients, suggesting a more favorable treatment response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pulmonology Department, Unidade Local de Saúde de Matosinhos, 4464-513 Porto, Portugal.
- Pulmonology Department, Unidade Local de Saúde da Região de Aveiro, 3814-501 Aveiro, Portugal.
- Pulmonology Department, Unidade Local de Saúde de São João, 4200-319 Porto, Portugal.
- Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
- Rise Health-Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
- Radiology Department, Unidade Local de Saúde de São João, 4200-319 Porto, Portugal.
ORCID-Profile: Joana Lourenço, David Barros Coelho, Patrícia Caetano Mota, Hélder Novais Bastos, António Morais
Zitieren
APA
Lourenço, J., Castro, S., Coelho, D. B., Alexandre, A. T., Melo, N., Mota, P. C., Bastos, H. N., Carvalho, A., & Morais, A. (2025). Unraveling the Complexities of Hypersensitivity Pneumonitis with Autoimmune Features: A Retrospective Analysis. Advances in Respiratory Medicine, 93(6), 50. https://doi.org/10.3390/arm93060050
Vancouver
Lourenço J, Castro S, Coelho DB, Alexandre AT, Melo N, Mota PC, et al. Unraveling the Complexities of Hypersensitivity Pneumonitis with Autoimmune Features: A Retrospective Analysis. Advances in Respiratory Medicine. 2025;93(6):50. doi:10.3390/arm93060050
BibTeX
@article{Loureno2025,
author = {Lourenço, Joana and Castro, Sofia and Coelho, David Barros and Alexandre, André Terras and Melo, Natália and Mota, Patrícia Caetano and Bastos, Hélder Novais and Carvalho, André and Morais, António},
title = {Unraveling the Complexities of Hypersensitivity Pneumonitis with Autoimmune Features: A Retrospective Analysis},
journal = {Advances in Respiratory Medicine},
year = {2025},
volume = {93},
number = {6},
pages = {50},
doi = {10.3390/arm93060050}
}
EUVIMED